Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMBR | Common Stock, par value $0.001 per share | Sale | -$60.6K | -47.7K | -0.88% | $1.27 | 5.39M | May 28, 2021 | Direct | F1 |
transaction | TMBR | Common Stock, par value $0.001 per share | Sale | -$11K | -8.67K | -0.16% | $1.26 | 5.38M | Jun 1, 2021 | Direct | F2 |
transaction | TMBR | Common Stock, par value $0.001 per share | Sale | -$12.4K | -9.88K | -0.18% | $1.26 | 5.37M | Jun 2, 2021 | Direct |
Id | Content |
---|---|
F1 | The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.32, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
F2 | The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |